BioVaria 2026 – Exzellente Technologien & Start-ups

Description

The BioVaria Conference is Europe’s leading life‑science innovation and technology transfer event, bringing together technology transfer professionals, academic researchers, start‑ups, investors and representatives from the biotech and pharmaceutical industries to showcase commercially attractive inventions and early‑stage ventures emerging from public research institutions across Europe. Over two days, participants present licensable technologies, engaging with potential partners and investors through curated pitches, expert presentations and interactive discussions that highlight breakthrough developments in therapeutics, diagnostics, platform technologies, medtech and digital health. BioVaria serves as a vital bridge between cutting‑edge academic research and commercial application, fostering collaborations that can accelerate innovation and market entry.
A key feature of the conference is the Startup Pitch & Partner programme, where selected start‑ups compete for visibility, mentorship and awards while connecting directly with venture capitalists and corporate development professionals during one‑on‑one speed‑dating sessions. The event also offers extensive networking opportunities throughout the programme, including informal receptions and thematic sessions that encourage deeper interaction among delegates. The 2026 edition will take place 27–28 April 2026 in Munich, Germany, and continues to attract top life‑science innovators and investors from across Europe and beyond.